More on IRD
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $3.90 |
|
|||
| Open | $3.90 | ||||
| 52 Wk High | $0.02 | ||||
| 52 Wk Low | $0.02 | ||||
| Day High | $3.90 | ||||
| Day Low | $3.90 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 4,067 | ||||
- Form 424B2 Opus Genetics, Inc.
- H.C. Wainwright Reiterates Buy Rating on Opus Genetics (IRD)
- Form EFFECT Opus Genetics, Inc.
- Opus Genetics (IRD) Reiterated at Market Outperform by Citizens after R&D Day
- Form 8-K Opus Genetics, Inc. For: Jun 16
- Opus Genetics outlines five gene therapy programs for retinal diseases
- Opus Genetics Highlights Five Gene Therapy Programs Targeting Significant Unmet Need in Patients with Inherited Retinal Diseases
- Form 8-K Opus Genetics, Inc. For: Jun 16
- Opus Genetics (IRD) Reiterated at Market Outperform by Citizens After Investor Meet
- Form S-3 Opus Genetics, Inc.
Entities mentioned with IRD
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Definitive Agreement | View Related Stories »
- Earnings | View Related Stories »
- 13G | View Related Stories »
- S3 | View Related Stories »
- Show More...
